Entry
Name
Ripasudil (USAN/INN)
Formula
C15H18FN3O2S
Exact mass
323.1104
Mol weight
323.39
Structure
Mol file KCF file DB search
Remark
Product (DG03329): D10463<JP >
Efficacy
Antiglaucoma, Rho-associated kinase inhibitor
Comment
Treatment of Fuchs endothelial corneal dystrophy
Target
Pathway
hsa04270 Vascular smooth muscle contraction
hsa04670 Leukocyte transendothelial migration
hsa04810 Regulation of actin cytoskeleton
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303 ]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EX Other antiglaucoma preparations
S01EX07 Ripasudil
D13014 Ripasudil (USAN/INN)
Target-based classification of drugs [BR:br08310 ]
Protein kinases
Serine/threonine kinases
AGC group
ROCK
D13014 Ripasudil (USAN/INN)
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 22
1 C1x C 16.5066 -14.6870
2 C1x C 15.6673 -13.5679
3 C1x C 15.9471 -12.1692
4 N1x N 17.2759 -11.6097
5 N1y N 17.9053 -14.6870
6 C1x C 18.4648 -12.2391
7 C1y C 18.8145 -13.5679
8 S4a S 17.9053 -16.0857
9 C8y C 17.9053 -17.4845
10 O3c O 19.3041 -16.0857
11 O3c O 16.5066 -16.0857
12 C8x C 16.7164 -18.1838
13 C8x C 16.7164 -19.5826
14 C8x C 17.9053 -20.2820
15 C8y C 19.0943 -19.5826
16 C8y C 19.0943 -18.1838
17 C8x C 20.3532 -20.2820
18 N5x N 21.5421 -19.5826
19 C8x C 21.5421 -18.1838
20 C8y C 20.3532 -17.4845
21 C1a C 20.2133 -13.8477
22 X F 20.3532 -16.0857
BOND 24
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 5 8 1
9 8 9 1
10 8 10 2
11 8 11 2
12 9 12 2
13 12 13 1
14 13 14 2
15 14 15 1
16 15 16 2
17 9 16 1
18 15 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 16 20 1
23 7 21 1 #Down
24 20 22 1